EKU2017.1: Non-alcoholic fatty liver disease

Respiratory disease, including infections, affects one in five people in England and is the third biggest cause of death, with around 68,000 annual deaths.In this podcast Dr Thomas Round talks to Professor Paul Little, a GP and Professor of Primary Care Research at the University ...  Show more

Irritable Bowel Syndrome (IBS) affects approximately 1 in 20 people in the UK, equating to around 3.2 million individuals, though some estimates suggest up to 1 in 5 adults experience symptoms, with potentially even more not seeking medical help. It's a common digestive disorder, ...  Show more

Drs Carol H. Wysham and Scott Isaacs discuss incorporating the screening and management of metabolic dysfunction–associated steatotic liver disease in endocrine practice. Relevant disclosures can be found with the episode show notes on Medscape https://www.medscape.com/viewarticl ...  Show more

Kristin Kirkpatrick, MS, RDN, renowned dietitian from the Cleveland Clinic and author of Skinny Liver and Regenerative Health explains why the liver is critical to health, and how Non-Alcoholic Fatty Liver Disease is a silent killer that has become an epidemic. With an estimated ...  Show more

Join Our Online Education Community "The School of Doza" Here: https://community.schoolofdoza.com/

This podcast episode focuses on fatty liver disease, a common issue affecting a significant number of adults in the United States. Nurse Doza, who is passionate a ...

Fatty liver disease is on the rise, but the good news is, it’s preventable and reversible. In this episode, I sit down with Dr. Yousef Elyaman to explore the silent epidemic and how early detection could be the key to saving your liver—and your health. We break down the latest in ...  Show more